Influence of the drugs used in migrant patients with severe acute respiratory syndrome coronavirus 2 and the development of symptomatic strongyloidiasis.
Helena LorenzoCristina CarbonellMaría Belén Vicente SantiagoAmparo López-BernusJosué Pendones UlerioJuan Luis Muñoz BellidoAntonio MuroMoncef Belhassen-GarcíaPublished in: Transactions of the Royal Society of Tropical Medicine and Hygiene (2021)
Screening programmes using serological techniques should be implemented in COVID-19 patients to prevent strongyloidiasis. Our study suggested that drugs used against COVID-19 in patients with strongyloidiasis did not affect the evolution of the disease. However, more studies are necessary to elucidate the role of dexamethasone in COVID-19 patients infected with Strongyloides.